Pulmo Biotech Inc (Grey Market:PLMO.PK)

Data as of Apr 10
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded in 2006 and is headquartered in New York, NY.

Contact Information

Pulmo BioTech, Inc.
1035 Park Avenue
New York New York 10028-0912
P:(646) 827-9362
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Garry McCannPresident, CEO, Treasurer & Director
Rajiv K. GargChief Financial Officer
Peter B. HirshfieldSecretary

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.